Presented by: Jan Hellemans, PhD, COO, pxlence

Available on demand

Are you eager to explore effective methods for validating quantitative PCR (qPCR) and Droplet Digital PCR (ddPCR) assays in regulated environments? Join us for this informative webinar presented by Jan Hellemans, COO of pxlence. Attendees will learn about the processes for validating qPCR and ddPCR assays during the transition from research use only (RUO) to in vitro diagnostic (IVD) status. Explore essential validation parameters, regulatory considerations, and real‑world case studies to expand your understanding of assay development in clinical research. These actionable insights and strategies are designed to help attendees ensure that their assays can meet rigorous standards.

Join us to learn about:

  • Validation approaches: learn effective methods to validate qPCR and ddPCR assays in research and clinical settings
  • RUO to IVD transition: understand the process and regulations for transitioning assays
  • Case studies and strategies: gain insights and strategies for navigating assay challenges in regulated settings
Watch Webinar
Previous post

A Polishing Strategy for Removing Impurities in Bispecific Antibody Purification

Next post

Effective Strategies for Endotoxin Removal in Therapeutic Protein Purification